Company intelligence / Profile preview

Trema

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

Novatrema Biotech is a Mumbai-based pharmaceutical company dedicated to the development, manufacturing, and marketing of high-quality healthcare products. The company offers a diverse portfolio of over 120 pharmaceutical products, including antibiotics, analgesics, gastrointestinal treatments, and nutritional supplements. With over a decade of experience in the Indian pharmaceutical market, Novatrema Biotech focuses on delivering innovative and affordable therapeutic solutions to healthcare professionals and patients. The company operates with a commitment to Good Manufacturing Practices (GMP) and maintains a strong distribution network across India.

Therapeutic areas: GastroenterologyNeurologyInfectious DiseasesMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Trema.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trema.

Explore the full profile